$3.46 -0.18 (-4.95%)

Cumberland Pharmaceuticals Inc (CPIX)

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing, licensing, and commercializing branded prescription products primarily for the hospital, emergency medicine, and specialty care markets. The company is known for its focus on niche therapeutic areas, including acute care and rare diseases, offering products that address unmet medical needs.

🚫 Cumberland Pharmaceuticals Inc does not pay dividends

Company News

RedHill Biopharma Receives Nasdaq Staff Determination Notification
Benzinga • Prnewswire • October 22, 2025

RedHill Biopharma received a Nasdaq Staff Determination letter indicating non-compliance with minimum stockholders' equity requirements. The company plans to appeal the determination and believes its recent transaction with Cumberland Pharmaceuticals has improved its equity position.

Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight
GlobeNewswire Inc. • Delveinsight • October 6, 2025

The diffuse cutaneous systemic sclerosis (dcSSc) market is evolving towards targeted therapies addressing fibrosis and immune modulation, with promising drug candidates from multiple pharmaceutical companies targeting various pathogenic pathways.

What Happened This Week: FedEx, The ‘Merge’ And Some Mighty Big Losers
Investing.com • Brenda O'Farrell/Investing.com • September 17, 2022

Top Trending Penny Stocks to Buy Now? 3 to Watch
PennyStocks • D. Marie • December 7, 2021

Check these three penny stocks out for your watchlist right now The post Top Trending Penny Stocks to Buy Now? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: What Moved Markets
Seeking Alpha • Wall Street Breakfast • December 4, 2021

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.